Internal Medicine · Freedom, CA
NPI
1447233622
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
99 Airport Blvd
Freedom, CA, 95019
Phone (831) 724-7521
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
1,480 services
Medicare patients, 2024
277
Average age 74
Drug cost, 2024
$903K
6,382 prescriptions
Company payments, 2025
$1,195
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco L Ravago was code 99215 (office e&m - established), 772 times for 241 patients. In total Francisco L Ravago billed 1,480 services in 25 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 772 | 241 | $127.64 | $99K |
| 99214 Office E&M - Established | Office | 188 | 123 | $86.98 | $16K |
| 99211 Office E&M - Established | Office | 116 | 45 | $16.52 | $1,916 |
| 93000 Electrocardiogram | Office | 96 | 87 | $8.69 | $834 |
| 0241U Infectious Agent Detection by DNA/RNA | Office | 66 | 50 | $139.78 | $9,225 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 51 | 51 | $44.39 | $2,264 |
| 93922 Duplex Scan - Extremity Arteries | Office | 49 | 49 | $57.24 | $2,805 |
| 99310 SNF E&M | Office | 24 | 16 | $108.58 | $2,606 |
| 99212 Office E&M - Established | Office | 21 | 18 | $40.59 | $852 |
| 51798 Ultrasound - Nonspecific | Office | 13 | 13 | $9.07 | $118 |
| 81002 Clinical Chemistry | Office | 12 | 11 | $3.41 | $40.92 |
By year: 2022 $152K for 1,653 services; 2023 $154K for 1,538 services; 2024 $140K for 1,480 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 0241U Infectious Agent Detection by DNA/RNA | 66 | 50 | $139.78 | $9,225 |
| 81002 Clinical Chemistry | 12 | 11 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Francisco L Ravago prescribed most often to Medicare patients was Atorvastatin Calcium, with 474 prescriptions and refills. In total Francisco L Ravago wrote 6,382 Medicare prescriptions that cost $903K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 474 | 1,056 | 113 | $5,027 |
| Amlodipine Besylate Generic | 361 | 863 | 83 | $3,451 |
| Levothyroxine Sodium Generic | 304 | 685 | 66 | $3,065 |
| Rosuvastatin Calcium Generic | 269 | 670 | 70 | $2,650 |
| Metformin Hcl Generic | 220 | 501 | 55 | $2,508 |
| Lisinopril Generic | 166 | 409 | 44 | $1,384 |
| Gabapentin Generic | 151 | 251 | 44 | $2,778 |
| Metoprolol Succinate Generic | 106 | 236 | 25 | $1,376 |
| Meloxicam Generic | 101 | 127 | 28 | $207 |
| Tamsulosin Hcl Generic | 98 | 229 | 26 | $1,807 |
| Pantoprazole Sodium Generic | 98 | 221 | 30 | $1,059 |
| Ezetimibe Generic | 88 | 186 | 21 | $3,838 |
| Omeprazole Generic | 88 | 239 | 27 | $1,976 |
| Furosemide Generic | 86 | 188 | 24 | $565 |
| Simvastatin Generic | 86 | 216 | 22 | $1,007 |
Brand drugs: 993 claims; generic drugs: 5,335 claims; opioid claims: 126.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco L Ravago $1,195 ($1,195 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $804.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $804 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $70.7 |
| Abbott Laboratories ABT | 2 | $38.63 |
| Paratek Pharmaceuticals, Inc. | 2 | $37.81 |
| GlaxoSmithKline, LLC. GSK | 1 | $30.36 |
| Dexcom, Inc. DXCM | 1 | $27.63 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $23.41 |
| Novo Nordisk Inc NVO | 1 | $14.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.